Condition guide · Clinician-reviewed

GLP-1s for Type 2 Diabetes & Prediabetes

GLP-1 receptor agonists are now a first-line option for type 2 diabetes, recommended by the American Diabetes Association alongside metformin for patients with cardiovascular risk or who need significant weight reduction. For prediabetes, evidence is rapidly accumulating that GLP-1s can prevent progression to T2D in high-risk patients.

Clinical evidence

  • SUSTAIN-6: Semaglutide reduced major adverse cardiovascular events by 26% in T2D patients vs placebo.
  • SURPASS-2: Tirzepatide 15mg lowered A1C by 2.3% — the largest reduction of any GLP-1-class trial.
  • STEP-1: 14.9% body weight loss on semaglutide 2.4mg — meaningful for insulin sensitivity in prediabetes.
  • ADA 2026 Standards of Care: GLP-1s recommended as preferred second-line agent for T2D with ASCVD or obesity.

Preferred medications

Programs we recommend

  1. #1 Editor's pick

    Mochi Health

    Obesity-medicine specialists with insurance navigation

    4.7
    $79/mo starting
    • Membership-only model is the cheapest entry point
    • Board-certified obesity medicine physicians
    • Will prescribe non-GLP-1 alternatives when appropriate
    • Medication paid separately
    🎁 Current offer

    $0 first visit

    Category:Prescription ProgramCoverage:All 50 statesInsurance:Accepted
  2. #2 Top rated

    Found

    Behavior-change first, medication when appropriate

    4.2
    $99/mo starting
    • Strong coaching curriculum
    • Personalized medication selection
    • Transparent about non-medication paths
    • Less GLP-1-centric than competitors
    🎁 Current offer

    First month $99

    Category:Prescription ProgramCoverage:All 50 statesInsurance:Accepted
  3. #3 Top rated

    Ro (Body)

    Brand-name Wegovy & Zepbound through insurance

    4.4
    $145/mo starting
    • Helps navigate insurance for brand-name GLP-1s
    • Polished mobile app and tracking
    • Access to compounded alternatives if insurance denies
    • Medication cost is separate when using insurance
    🎁 Current offer

    $99 first month

    Category:Telehealth GLP-1Coverage:All 50 statesInsurance:Accepted

Clinical considerations

Insurance coverage is much stronger when a T2D diagnosis is documented — most commercial plans cover Ozempic and Mounjaro for diabetes. Monitor for hypoglycemia when combined with insulin or sulfonylureas. Renal function should be checked before initiating in patients with CKD.

FAQ

GLP-1s for Type 2 Diabetes & Prediabetes FAQs

Per the ADA's 2026 Standards of Care, metformin remains first-line, but GLP-1s are preferred second-line — and first-line in patients with ASCVD, heart failure, or obesity. Many endocrinologists now start GLP-1s alongside metformin.

Other condition guides

Related cost, coverage & program reviews